A new trading day began on January 24, 2023, with Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) stock priced at $26.45, up 2.87% from the previous day of trading. During the day, the shares moved up to $27.30 and dropped to $26.26 before settling in for the closing price of $26.47. SNDX’s price has ranged from $13.27 to $27.68 over the past 52 weeks.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Healthcare Sector giant saw their annual sales surged by 158.10% over the last five years. Meanwhile, its annual earnings per share averaged 124.90%. With a float of $57.43 million, this company’s outstanding shares have now reached $60.67 million.
The firm has a total of 59 workers. Let’s measure their productivity. In terms of profitability, gross margin is +99.67, operating margin of +18.77, and the pretax margin is +17.84.
Syndax Pharmaceuticals Inc. (SNDX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Syndax Pharmaceuticals Inc. is 0.30%, while institutional ownership is 90.20%. The most recent insider transaction that took place on Jan 13, was worth 405,000. In this transaction Director of this company sold 15,000 shares at a rate of $27.00, taking the stock ownership to the 32,000 shares. Before that another transaction happened on Jan 12, when Company’s Director sold 24,000 for $26.74, making the entire transaction worth $641,782. This insider now owns 32,000 shares in total.
Syndax Pharmaceuticals Inc. (SNDX) Earnings and Forecasts
In its latest quarterly report, released on 6/29/2022, the company reported earnings of -$0.62 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of +17.84 while generating a return on equity of 7.55. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 124.90% per share during the next fiscal year.
Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) Trading Performance Indicators
Here are Syndax Pharmaceuticals Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 17.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.22, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.48 in one year’s time.
Technical Analysis of Syndax Pharmaceuticals Inc. (SNDX)
Analysing the last 5-days average volume posted by the [Syndax Pharmaceuticals Inc., SNDX], we can find that recorded value of 0.58 million was lower than the volume posted last year of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 74.04%. Additionally, its Average True Range was 1.17.
During the past 100 days, Syndax Pharmaceuticals Inc.’s (SNDX) raw stochastic average was set at 93.95%, which indicates a significant increase from 88.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.26% in the past 14 days, which was lower than the 55.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.99, while its 200-day Moving Average is $21.25. Now, the first resistance to watch is $27.60. This is followed by the second major resistance level at $27.97. The third major resistance level sits at $28.64. If the price goes on to break the first support level at $26.56, it is likely to go to the next support level at $25.89. Should the price break the second support level, the third support level stands at $25.52.
Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) Key Stats
With a market capitalization of 1.84 billion, the company has a total of 60,223K Shares Outstanding. Currently, annual sales are 139,710 K while annual income is 24,930 K. The company’s previous quarter sales were 0 K while its latest quarter income was -35,403 K.